No Carolina / NY / Florida
Ph: 561.316.3330

BioConnects New England (BCNE) Partners with Thermo Fisher, Mass Life Sciences Center and Northeastern University to Host Booth at JA Inspire

Summation

  • “It was great to join forces with two of our closest partners in BCNE and ThermoFisher Scientific at JA Inspire to highlight the MLSC internship programs and other resources for students interested in life sciences careers,” said Ryan Mudawar, VP of Education and Workforce Programs at the MLSC.
  • BioConnects New England (BCNE) partnered with Thermo Fisher Scientific and the Massachusetts Life Sciences Center (MLSC) to introduce 8th-grade students to career opportunities in the life sciences at the Junior Achievement of Greater Boston's JA Inspire expo held at Boston's Hynes Convention Center in December.
  • “JA Inspire is a one-of-a-kind event where we can interact with young learners and really get them thinking about careers in biomanufacturing and the life sciences in companies, labs, and academic and research institutions across New England.

BioConnects New England

BioConnects New England (BCNE) partnered with Thermo Fisher Scientific and the Massachusetts Life Sciences Center (MLSC) to introduce 8th-grade students to career opportunities in the life sciences at the Junior Achievement of Greater Boston’s JA Inspire expo held at Boston’s Hynes Convention Center in December.

JA Inspire

JA Inspire is a powerful event designed to share career opportunities with 1,200 middle school students from cities such as Boston, Chelsea, Lawrence, Lowell, Lynn, and Quincy. “It was great to join forces with two of our closest partners in BCNE and ThermoFisher Scientific at JA Inspire to highlight the MLSC internship programs and other resources for students interested in life sciences careers,” said Ryan Mudawar, VP of Education and Workforce Programs at the MLSC. “It was truly energizing to engage with hundreds of local middle and high school students and help them understand the great potential and opportunity that the life sciences industry can offer them right here in Massachusetts.”

Volunteering with JA Inspire

“Volunteering with JA Inspire was such an impactful experience that allowed us to introduce the intersection between science and business to young students,” Jordyn Blake, biosciences account manager at ThermoFisher’s Life Sciences Solutions Group in Boston, said. “They were so engaged in learning about career pathways outside of the traditional STEM careers.  I am glad we were able to play a part in inspiring the next generation of innovators and scientists by sharing our journeys.”

“Northeastern seeks to bring the best of its resources and reach to events like JA Inspire. Our research government affairs and BioConnects New England teams collaborate regularly on these opportunities to drive tangible impact locally,” said Dana DeBari, Director of Government Relations & Strategic Projects at Northeastern. “JA Inspire is a one-of-a-kind event where we can interact with young learners and really get them thinking about careers in biomanufacturing and the life sciences in companies, labs, and academic and research institutions across New England.”

Future of Biotech

BCNE believes that the future of biotech relies heavily on creating access, education, and connection to the industry for young people. Junior Achievement Boston has built a brilliant opportunity with its annual JA Inspire Event.

More News

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment

The new Roden ADA Kit expedites bioanalysis by removing the need for assay development and optimization across molecules to provide robust, reproducible, reliable data from nanoliter sample volumes. This is beneficial when ADA assessment is evaluated in preclinical animal models where sample volume may be limited.

Unleashing Biotech Potential: ATLATL Scientific & Miltenyi Biotec Partnership

Since the inception of their partnership five years ago, ATLATL Scientific and Miltenyi Biotec have worked closely together to leverage their respective expertise and resources.

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy